Almost every provider publishes a starting price. Very few publish what you pay once you are stable on a maintenance dose eighteen months in. That silence is the most expensive information gap in the category.
Key Takeaways
- Most providers price the acquisition, not the retention — the published number is aimed at signups.
- Flat-price providers are the only ones where the maintenance number is knowable in advance with confidence.
- Tiered providers can be estimated by reading the dose-tier schedule, where one is published.
- SHED publishes a maintenance-tier price increase explicitly, which is unusual and worth crediting even though the number is higher.
- The right question at signup is not 'what does this cost' but 'what does this cost at 2.4 mg semaglutide or 10 mg tirzepatide'.
How we built this table
Every figure here comes from the provider's own published pricing or intake flow as of our most recent verification pass. Where a provider publishes a range rather than a single number, we show the range. Where pricing only appears after you complete an intake, we say so rather than guessing. We do not estimate, average, or fill gaps — a blank is a blank.
Prices in this category move often. Treat this table as a starting shortlist and confirm the current number at checkout before you commit to a multi-month plan.
| Provider | Maintenance rate published? | What year two looks like |
|---|---|---|
| Telos Rx | Effectively yes — flat by plan length | Same monthly rate you started on for that plan; renewal terms apply |
| Wellorithm | Yes — per format | Published oral and injectable rates hold across doses |
| Strut Health ⚠️ | Yes — published band | Sublingual rate published as a flat figure |
| SHED | Yes, explicitly | Tirzepatide rises to $399/mo at the 7.5 mg and higher maintenance tiers; initial term converts to a different ongoing rate |
| Yucca Health | Partly | Ongoing monthly rate published ($275 sema / $385 tirz) alongside 6-month plan rates |
| MadeMed | Partly | Tiers published by dose; higher tiers price upward from the starting figure |
| Found Health | Yes | Per-4-week rate published; remember 13 cycles a year |
| Care Bare Rx | No | Surfaces during intake only |
| Ageless | No | Surfaces during intake only |
Why maintenance is where the money is
Weight-loss induction is a phase. Maintenance, on the current evidence about what happens when treatment stops, is potentially indefinite. If you are on this medication for three years, roughly thirty of those thirty-six months are at a maintenance dose. The starting price governs a small minority of your total spend.
Run the arithmetic before you sign up. A provider at $149 starting and $349 maintaining costs substantially more over three years than one at $229 flat, despite winning every headline comparison.
SHED
Multi-format- Carries brand-name options alongside compounded: Wegovy pen $199, oral Wegovy pill $149, Zepbound $349 plus a $99 membership
- 120-day results guarantee (terms updated June 10, 2026)
- Multi-month terms convert to a different ongoing rate — read the conversion language
Price-jump disclosure: SHED's tirzepatide pricing increases to $399/mo once you reach the 7.5 mg maintenance tier. Budget for the higher number, not the entry number.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Wellorithm
Lowest published oral price- Compounded tablet format — no needles, no cold chain
- Publishes per-format pricing rather than bundling everything into one plan
- Injectable options also offered
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Telos Rx (Tirzepatide)
Flat pricing by plan length- Price is flat regardless of dose tier once your plan is set
- 12-month plan carries the lowest monthly rate; 1-month is the highest
- Cancel anytime; FSA/HSA accepted
Telos publishes plan-length pricing rather than dose-tier pricing, so the number you see at signup depends on the commitment you choose, not the milligrams you take.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
How to estimate an unpublished maintenance rate
Three approaches, in order of reliability:
Ask before you sign up. Message support with a specific question: what is the monthly cost at 2.4 mg semaglutide, or at 10 mg tirzepatide? A provider that answers plainly has told you something. A provider that deflects has told you something too.
Read the dose-tier schedule. Where one is published, the top tier is your maintenance number. It is often on a pricing or FAQ page rather than the landing page.
Assume the published band's upper end. When a provider publishes a range, plan for the top of it. You will rarely be unpleasantly surprised, and occasionally pleasantly.
Yucca Health
Injectable only- Clear intro-versus-ongoing split published up front
- Free UPS 2-Day Air shipping
- Klarna, Affirm and Afterpay available on 6-month plans
Injectable only. Yucca's headline promo rate is tied to the 6-month new-patient plan — the month-to-month rate is substantially higher.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
MadeMed (Injectable Tirzepatide)
Injectable- Priced close to the semaglutide line rather than at a large premium
- Quarterly billing lowers the effective monthly rate
- Dose increases are priced per tier — confirm your tier at checkout
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Found Health
4-week billing cycle- Bills in 4-week cycles, not calendar months — 13 cycles a year, not 12
- Behavior-change coaching bundled with the medication track
- Dissolvable tablet format
A 4-week cycle means your true annual cost is 13 × the quoted price. Worth doing the multiplication before comparing against a monthly-billed competitor.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Frequently Asked Questions
What is a maintenance dose?
The dose you stabilize on after escalation. For semaglutide that is commonly the upper end of the escalation schedule; for tirzepatide it varies more widely by individual response and tolerance.
Do providers raise prices between year one and year two?
Some publish an explicit conversion after an initial term. Others simply reprice by dose tier as you escalate. Both produce a higher year-two cost than the signup price.
Is flat pricing always cheaper long-term?
Not always — a flat rate set high enough can exceed a tiered provider's mid-range tier. What flat pricing reliably provides is predictability, which has value independent of the number.
Can you negotiate maintenance pricing?
Retention offers exist in this market, and asking when you are considering cancelling sometimes produces one. It is not a documented policy anywhere and should not factor into your initial choice.